Picture of Oncolys Biopharma logo

4588 — Oncolys Biopharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Table: Oncolys Biopharma - 6-MTH parent results

Aug 6 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            193 mln             136 mln                    
                 (+41.8 pct)         (-78.1 pct)                  
  Operating     loss 633 mln        loss 660 mln                  
  Recurring     loss 649 mln        loss 662 mln                  
  Net           loss 650 mln        loss 664 mln                  
  EPS          loss 39.45 yen      loss 46.43 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T

Recent news on Oncolys Biopharma

See all news